Activation of carcinogens by human liver cytochromes P-450. 1990

F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
Department of Biochemistry, Vanderbilt University, Nashville, Tennessee 37232.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
July 1983, The New England journal of medicine,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
January 1986, Basic life sciences,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
January 1984, Xenobiotica; the fate of foreign compounds in biological systems,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
December 1991, Gastroenterology,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
January 1969, Clinical pharmacology and therapeutics,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
April 1993, European journal of biochemistry,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
February 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
December 1993, Cancer research,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
May 1982, Biochemistry,
F P Guengerich, and T Shimada, and M Iwasaki, and M A Butler, and F F Kadlubar
February 1988, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!